ChOcolate COnsumption And Blood Pressure (COCOA-BP): A Wearable Devices Pilot Trial
- Conditions
- Blood PressureHealth Behavior
- Interventions
- Other: Dark ChocolateDevice: Wearable devices
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2017-10-04
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 67
- Registration Number
- NCT02764203
VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation
- Conditions
- Chronic Pain
- Interventions
- Device: Spinal Cord Stimulation (SCS) System
- First Posted Date
- 2016-04-18
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 73
- Registration Number
- NCT02741297
- Locations
- ๐ฉ๐ช
Schreiber Klinik, Muenchen, Germany
๐ฎ๐นAzienda Ospedale Monaldi, Naples, Italy
๐ณ๐ฑZiekenhuis Rijnstate, Velp, Netherlands
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
- Conditions
- Peripheral Arterial Disease
- Interventions
- Device: Jetstream Atherectomy System
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT02733653
- Locations
- ๐ฏ๐ต
Nagoya Kyoritsu Hospital, Nagoya, Aichi, Japan
๐ฏ๐ตKokura Memorial Hospital, Kokura, Fukuoka, Japan
๐ฏ๐ตIwaki Kyouritsu Hospital, Iwaki, Fukushima, Japan
Investigational Device Evaluation of the WATCHMAN FLXโข LAA Closure Technology
- Conditions
- Atrial Fibrillation
- Interventions
- Device: WATCHMAN FLX
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 458
- Registration Number
- NCT02702271
- Locations
- ๐บ๐ธ
Grandview Medical Center, Birmingham, Alabama, United States
๐บ๐ธPhoenix Cardiovascular Research Group, Phoenix, Arizona, United States
๐บ๐ธSt. Joseph's Hospital & Medical Center, Phoenix, Arizona, United States
Prospective Registry on User Experience With The Mapping System For Ablation Procedures
- Conditions
- Cardiac Arrhythmias
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 577
- Registration Number
- NCT02698670
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, Birmingham, Alabama, United States
๐บ๐ธHoag Memorial Hospital, Orange, California, United States
๐บ๐ธTorrance Memorial Medical Center, Torrance, California, United States
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy
- Conditions
- Colorectal Carcinoma
- Interventions
- Device: 40um Embozene TANDEM Microspheres
- First Posted Date
- 2016-02-29
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT02694562
- Locations
- ๐ฎ๐น
European Institute of Oncology, Milan, Italy
Verciseโข DBS Dystonia Prospective Study
- Conditions
- Dystonia
- First Posted Date
- 2016-02-19
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT02686125
- Locations
- ๐จ๐ฆ
Queen Elizabeth II Health Sciences Center, Halifax, Canada
๐ง๐ชAZ Sint-Lucas, Ghent, Belgium
๐ง๐ชUZ Gasthuisberg, Leuven, Belgium
Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings
- Conditions
- Stone Clearance
- Interventions
- Device: Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02683993
- Locations
- ๐บ๐ธ
New York Methodist Hospital, New York, New York, United States
Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH
- Conditions
- Treatment of Benign Prostatic Hyperplasia
- Interventions
- Device: Lumenis Pulse P120H and Xpeeda side firing fiber
- First Posted Date
- 2016-02-17
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT02683980
- Locations
- ๐บ๐ธ
New York Methodist Hospital, New York, New York, United States
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)
- Conditions
- Non-valvular Atrial Fibrillation
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT02654470
- Locations
- ๐ฉ๐ฐ
Aarhus University Hospital, Aarhus, Denmark
๐ซ๐ทHospices Civils de Lyon, Lyon, France
๐ฉ๐ชElisabeth Krankenhaus, Essen, Germany